BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 19373535)

  • 1. Follow-up magnetic resonance imaging findings in patients with progressive multifocal leukoencephalopathy: evaluation of long-term survivors under highly active antiretroviral therapy.
    Sakai M; Inoue Y; Aoki S; Sirasaka T; Uehira T; Takahama S; Nagai H; Yutani K; Yoshikawa K; Nakamura H
    Jpn J Radiol; 2009 Feb; 27(2):69-77. PubMed ID: 19373535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Initial and follow-up MR imaging findings in AIDS-related progressive multifocal leukoencephalopathy treated with highly active antiretroviral therapy.
    Thurnher MM; Post MJ; Rieger A; Kleibl-Popov C; Loewe C; Schindler E
    AJNR Am J Neuroradiol; 2001 May; 22(5):977-84. PubMed ID: 11337345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of diffusion-weighted imaging to evaluate the initial response of progressive multifocal leukoencephalopathy to highly active antiretroviral therapy: early experience.
    Buckle C; Castillo M
    AJNR Am J Neuroradiol; 2010 Jun; 31(6):1031-5. PubMed ID: 20360338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progressive multifocal leukencephalopathy in patients on highly active antiretroviral therapy: survival and risk factors of death.
    Wyen C; Hoffmann C; Schmeisser N; Wöhrmann A; Qurishi N; Rockstroh J; Esser S; Rieke A; Ross B; Lorenzen T; Schmitz K; Stenzel W; Salzberger B; Fätkenheuer G
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1263-8. PubMed ID: 15385733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy.
    Albrecht H; Hoffmann C; Degen O; Stoehr A; Plettenberg A; Mertenskötter T; Eggers C; Stellbrink HJ
    AIDS; 1998 Jul; 12(10):1149-54. PubMed ID: 9677163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Progressive multifocal leukoencephalopathy in patients with AIDS: is there a change in patients treated with highly active antiretroviral therapies?].
    Montes Santiago J; Pérez Fernández E; González Vázquez L; Morano Amado L; Fernández Martín J; Asorey Carballeira A; Pérez Alvarez R
    An Med Interna; 2002 May; 19(5):230-3. PubMed ID: 12107996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The inefficacy of zidovudine (AZT) in progressive multifocal leukoencephalopathy (PML) associated with the acquired immunodeficiency syndrome (AIDS)].
    Garrote FJ; Molina JA; Lacambra C; Mollejo M; Madero S; del Ser T
    Rev Clin Esp; 1990 Nov; 187(8):404-7. PubMed ID: 2091134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive multifocal leukoencephalopathy in an HIV patient receiving successful long-term HAART.
    Mascarello M; Lanzafame M; Lattuada E; Concia E; Ferrari S
    J Neurovirol; 2011 Apr; 17(2):196-9. PubMed ID: 21445699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.
    Tantisiriwat W; Tebas P; Clifford DB; Powderly WG; Fichtenbaum CJ
    Clin Infect Dis; 1999 May; 28(5):1152-4. PubMed ID: 10452651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy.
    Vendrely A; Bienvenu B; Gasnault J; Thiebault JB; Salmon D; Gray F
    Acta Neuropathol; 2005 Apr; 109(4):449-55. PubMed ID: 15739098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy treated with highly active anti-retroviral therapy].
    Shimizu Y; Ota K; Takeuchi M; Iwata M; Yogo Y
    Rinsho Shinkeigaku; 2000 Aug; 40(8):821-6. PubMed ID: 11218704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course and prognostic factors of progressive multifocal leukoencephalopathy in patients treated with highly active antiretroviral therapy.
    Berenguer J; Miralles P; Arrizabalaga J; Ribera E; Dronda F; Baraia-Etxaburu J; Domingo P; Márquez M; Rodriguez-Arrondo FJ; Laguna F; Rubio R; Lacruz Rodrigo J; Mallolas J; de Miguel V;
    Clin Infect Dis; 2003 Apr; 36(8):1047-52. PubMed ID: 12684918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune reconstitution after potent antiretroviral therapy in AIDS patients with progressive multifocal leukoencephalopathy.
    D'Amico R; Sarkar S; Yusuff J; Azar E; Perlman DC
    Scand J Infect Dis; 2007; 39(4):347-50. PubMed ID: 17454900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.
    Ferrante P; Delbue S; Pagani E; Mancuso R; Marzocchetti A; Borghi E; Maserati R; Bestetti A; Cinque P
    J Neurovirol; 2003; 9 Suppl 1():42-6. PubMed ID: 12709871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remission of progressive multifocal leukoencephalopathy following highly active antiretroviral therapy in a patient with HIV infection.
    Inui K; Miyagawa H; Sashihara J; Miyoshi H; Tanaka-Taya K; Nishigaki T; Teraoka S; Mano T; Ono J; Okada S
    Brain Dev; 1999 Sep; 21(6):416-9. PubMed ID: 10487477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of highly active antiretroviral therapy-induced immune reconstitution on development and outcome of progressive multifocal leukoencephalopathy: study of 43 cases with review of the literature.
    Cinque P; Bossolasco S; Brambilla AM; Boschini A; Mussini C; Pierotti C; Campi A; Casari S; Bertelli D; Mena M; Lazzarin A
    J Neurovirol; 2003; 9 Suppl 1():73-80. PubMed ID: 12709876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients.
    Huang D; Cossoy M; Li M; Choi D; Taege A; Staugaitis SM; Rehm S; Ransohoff RM
    Ann Neurol; 2007 Jul; 62(1):34-9. PubMed ID: 17328067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.
    Giancola ML; Rizzi EB; Lorenzini P; Rovighi L; Baldini F; Schininà V; Larussa D; Bibbolino C; Antinori A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):155-62. PubMed ID: 18240958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and prognosis of immune reconstitution inflammatory syndrome in HIV-associated progressive multifocal leucoencephalopathy.
    Sainz-de-la-Maza S; Casado JL; Pérez-Elías MJ; Moreno A; Quereda C; Moreno S; Corral I
    Eur J Neurol; 2016 May; 23(5):919-25. PubMed ID: 26914970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity?
    Di Giambenedetto S; Vago G; Pompucci A; Scoppettuolo G; Cingolani A; Marzocchetti A; Tumbarello M; Cauda R; De Luca A
    Neurology; 2004 Dec; 63(12):2452-3. PubMed ID: 15623736
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.